Joost van der Hoek

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5

Leo J. Hofland, Joost van der Hoek, Richard A. Feelders et al. · European Journal of Endocrinology · 2005 · 274 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

A Case Series of Proton Pump Inhibitor–Induced Hypomagnesemia

Ewout J. Hoorn, Joost van der Hoek, Rob A. de Man et al. · American Journal of Kidney Diseases · 2010 · 230 citations

Natural Sciences, Pharmacotherapy, Magnetic Materials +7

The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas<i>in Vitro</i>

Leo J. Hofland, Joost van der Hoek, Peter M. van Koetsveld et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 180 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells

Joost van der Hoek, Marlijn Waaijers, Peter M. van Koetsveld et al. · American Journal of Physiology-Endocrinology and Metabolism · 2005 · 152 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients

Joost van der Hoek, Wouter W. de Herder, Richard A. Feelders et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 142 citations · Full text

Medicine, Endocrinology, Pharmacology +17